Annals of the New York Academy of Sciences

© The New York Academy of Sciences

Cover image for Vol. 1132 Myasthenia Gravis and Related Disorders 11th International Conference

June 2008

Volume 1132 Myasthenia Gravis and Related Disorders 11th International Conference

Pages xiii–xiii, 1–393

  1. Preface

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Preface (page xiii)

      Henry J. Kaminski and Richard J. Barohn

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.043

  2. Part I. Structure and Function of the Neuromuscular Junction

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Structural Factors Influencing the Efficacy of Neuromuscular Transmission (pages 1–12)

      Clarke R. Slater

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.003

    2. Cell-to-Cell Signaling at the Neuromuscular Junction : The Dynamic Role of the Extracellular Matrix (pages 13–18)

      Michael J. Werle

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.035

    3. The Role of Glial Cells in the Formation and Maintenance of the Neuromuscular Junction (pages 19–28)

      Zhihua Feng and Chien-Ping Ko

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.016

  3. Part II. Structure and Function of the Acetylcholine Receptor

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Myasthenia Gravis and the Tops and Bottoms of AChRs : Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains (pages 29–41)

      Jon Lindstrom, Jie Luo and Alexander Kuryatov

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.007

    2. Functional Organization and Conformational Dynamics of the Nicotinic Receptor : A Plausible Structural Interpretation of Myasthenic Mutations (pages 42–52)

      Antoine Taly and Jean-Pierre Changeux

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.008

    3. Recent Structural and Mechanistic Insights into Endplate Acetylcholine Receptors (pages 53–60)

      Steven M. Sine, Fan Gao, Won Yong Lee, Nuriya Mukhtasimova, Hai-Long Wang and Andrew G. Engel

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.041

    4. Peptide-Toxin Tools for Probing the Expression and Function of Fetal and Adult Subtypes of the Nicotinic Acetylcholine Receptor (pages 61–70)

      Russell W. Teichert, Carmen C. Garcia, Joseph G. Potian, James J. Schmidt, Veit Witzemann, Baldomero M. Olivera and Joseph J. McArdle

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.015

  4. Part III. Muscle-Specific Kinase and Myasthenia Gravis

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Clinical Phenotype of Muscle-specific Tyrosine Kinase-antibody-positive Myasthenia Gravis (pages 71–75)

      Gil I. Wolfe and Shin J. Oh

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.005

    2. Response to Therapy in Myasthenia Gravis with Anti-MuSK Antibodies (pages 76–83)

      Amelia Evoli, Maria R. Bianchi, Raffaella Riso, Giacomo M. Minicuci, Anna P. Batocchi, Serenella Servidei, Flavia Scuderi and Emanuela Bartoccioni

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.012

    3. Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies (pages 84–92)

      Angela Vincent, Maria Isabel Leite, Maria Elena Farrugia, Saiju Jacob, Stuart Viegas, Hiro Shiraishi, Olivier Benveniste, B. Paul Morgan, David Hilton-Jones, John Newsom-Davis, David Beeson and Nick Willcox

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.020

    4. Myasthenia Gravis Experimentally Induced with Muscle-specific Kinase (pages 93–98)

      Kazuhiro Shigemoto, Sachiho Kubo, Chen Jie, Naohito Hato, Yasuhito Abe, Norifumi Ueda, Naoto Kobayashi, Kenji Kameda, Katsumi Mominoki, Atsuo Miyazawa, Akihito Ishigami, Seiji Matsuda and Naoki Maruyama

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.002

  5. Part IV. Congenital Myasthenic Syndromes

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Congenital Myasthenic Syndromes and the Formation of the Neuromuscular Junction (pages 99–103)

      David Beeson, Richard Webster, Judith Cossins, Daniel Lashley, Hayley Spearman, Susan Maxwell, Clarke R. Slater, John Newsom-Davis, Jacqueline Palace and Angela Vincent

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.049

    2. Further Observations in Congenital Myasthenic Syndromes (pages 104–113)

      Andrew G. Engel, Xin-Ming Shen, Duygu Selcen and Steven M. Sine

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.039

  6. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Anti-ganglioside Antibodies and the Presynaptic Motor Nerve Terminal (pages 114–123)

      Hugh J. Willison and Jaap J. Plomp

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.010

    2. Neuronal Acetylcholine Receptor Autoimmunity (pages 124–128)

      Steven Vernino

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.011

    3. Lambert–Eaton Myasthenic Syndrome : Tumor versus Nontumor Forms (pages 129–134)

      Maarten J. Titulaer and Jan J.G.M. Verschuuren

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.030

  7. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Regulatory and Pathogenic Mechanisms in Human Autoimmune Myasthenia Gravis (pages 135–142)

      Rozen Le Panse, Géraldine Cizeron-Clairac, Mélinée Cuvelier, Frédérique Truffault, Jacky Bismuth, Patrice Nancy, Nicole Kerlero De Rosbo and Sonia Berrih-Aknin

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.019

    2. Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis : Role of MHC Class II and AIRE Genes and Genetic Polymorphisms (pages 143–156)

      Philipp Ströbel, Wen-Yu Chuang, Sergei Chuvpilo, Andreas Zettl, Tiemo Katzenberger, Hubert Kalbacher, Peter Rieckmann, Wilfred Nix, Berthold Schalke, Ralf Gold, Hans-Konrad Müller-Hermelink, Pärt Peterson and Alexander Marx

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.018

    3. How Promiscuity Promotes Tolerance: The Case of Myasthenia Gravis (pages 157–162)

      Bruno Kyewski and Richard Taubert

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.026

    4. Autoimmunizing Mechanisms in Thymoma and Thymus (pages 163–173)

      Nick Willcox, Maria Isabel Leite, Yoshihisa Kadota, Margaret Jones, Anthony Meager, Peddasomayajula Subrahmanyam, Bhaskar Dasgupta, B. Paul Morgan and Angela Vincent

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.021

    5. Treatment of Myasthenia Gravis by Preventing Acetylcholine Receptor Modulation (pages 174–179)

      Mario Losen, Pilar Martínez-Martínez, Marko Phernambucq, Janine Schuurman, Paul W.H.I. Parren and Marc H. De Baets

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.034

    6. Genetic Factors in Autoimmune Myasthenia Gravis (pages 180–192)

      Matthieu Giraud, Claire Vandiedonck and Henri-Jean Garchon

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.027

    7. CD4+ T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis (pages 193–209)

      Bianca M. Conti-Fine, Monica Milani and Wei Wang

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.042

    8. Classical Complement Pathway in Experimental Autoimmune Myasthenia Gravis Pathogenesis (pages 210–219)

      Premkumar Christadoss, Erdem Tüzün, Jing Li, Shamsher S. Saini and Huan Yang

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.009

    9. Extraocular Muscle Susceptibility to Myasthenia Gravis : Unique Immunological Environment? (pages 220–224)

      Jindrich Soltys, Bendi Gong, Henry J. Kaminski, Yuefang Zhou and Linda L. Kusner

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.037

  8. Part VII. Clinical Trials of Myasthenia Gravis

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Treatment and Clinical Research in Myasthenia Gravis : How Far Have We Come? (pages 225–232)

      Richard J. Barohn

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.036

    2. Rules of Evidence for Clinical Trials : The Science of Finding the Truth? (pages 233–237)

      Gary Cutter and Inmaculada Aban

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.025

    3. Myasthenia Gravis in the Elderly : Is It Different? (pages 238–243)

      Johan A. Aarli

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.040

    4. Immunosuppression of EAMG by IVIG Is Mediated by a Disease-specific Anti-immunoglobulin Fraction (pages 244–248)

      Sara Fuchs, Tali Feferman, Roberto Meidler, Raanan Margalit, Camille Sicsic, Talma Brenner, Orgad Laub and Miriam C. Souroujon

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.032

    5. Lessons from Two Trials of Mycophenolate Mofetil in Myasthenia Gravis (pages 249–253)

      Donald B. Sanders and Zaeem A. Siddiqi

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.031

    6. Tacrolimus for Myasthenia Gravis : A Clinical Study of 212 Patients (pages 254–263)

      José M. Ponseti, Josep Gamez, Jamal Azem, Manuel López-Cano, Ramón Vilallonga and Manuel Armengol

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.000

    7. IVIG Treatment for Myasthenia Gravis : Effectiveness, Limitations, and Novel Therapeutic Strategies (pages 264–270)

      Lorne Zinman and Vera Bril

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.038

    8. Treatment of Myasthenia Gravis Acute Exacerbations with Intravenous Immunoglobulin (pages 271–275)

      Philippe Gajdos and Sylvie Chevret

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.001

  9. Part VIII. Treatments on the Horizon for Myasthenia Gravis

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Strategies for Treating Autoimmunity : Novel Insights from Experimental Myasthenia Gravis (pages 276–282)

      Matthew N. Meriggioli, Jian Rong Sheng, Liangcheng Li and Bellur S. Prabhakar

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.023

    2. Antisense Treatment for Myasthenia Gravis : Experience with Monarsen (pages 283–290)

      Jon D. Sussman, Zohar Argov, David McKee, Eli Hazum, Solli Brawer and Hermona Soreq

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.022

    3. Antigen-specific Apheresis of Pathogenic Autoantibodies from Myasthenia Gravis Sera (pages 291–299)

      Socrates J. Tzartos, Kalliopi Bitzopoulou, Ira Gavra, Grigoris Kordas, Leslie Jacobson, Kalliopi Kostelidou, George Lagoumintzis, Orestis Lazos, Kostantinos Poulas, Sotiris Sideris, Alexandros Sotiriadis, Nikos Trakas and Paraskevi Zisimopoulou

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.017

    4. Etanercept Treatment in Myasthenia Gravis (pages 300–304)

      Julie Rowin

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.028

    5. Rebooting the Immune System with High-Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis (pages 305–314)

      Daniel B. Drachman, Robert N. Adams, Rong Hu, Richard J. Jones and Robert A. Brodsky

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.033

  10. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Thymectomy for Nonthymomatous Myasthenia Gravis : A Critical Analysis (pages 315–328)

      Joshua R. Sonett and Alfred Jaretzki III

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.004

    2. Thoracoscopic Thymectomy with the da Vinci Robotic System for Myasthenia Gravis (pages 329–335)

      Jens C. Rückert, Mahmoud Ismail, Marc Swierzy, Holger Sobel, Patrik Rogalla, Andreas Meisel, Klaus D. Wernecke, Ralph I. Rückert and Joachim M. Müller

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.013

    3. Extended Transcervical Thymectomy in the Treatment of Myasthenia Gravis (pages 336–343)

      Sanjay G. Khicha, Larry R. Kaiser and Joseph B. Shrager

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.006

    4. Status of the Thymectomy Trial for Nonthymomatous Myasthenia Gravis Patients Receiving Prednisone (pages 344–347)

      John Newsom-Davis, Gary Cutter, Gil I. Wolfe, Henry J. Kaminski, Alfred Jaretzki III, Greg Minisman, Inmaculada Aban and Robin Conwit

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.014

  11. List of Abstracts

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. List of Abstracts (pages 348–386)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.044

  12. Erratum

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. You have free access to this content
      Erratum for Ann. N.Y. Acad. Sci. 1010: 441–445. Apoptosis: From Signaling Pathways to Therapeutic Tools Marc Diederich, Ed. (page 387)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.045

      This article corrects:

      Rescue of Cells from Apoptosis by Antioxidants Occurs Downstream from GSH Extrusion

      Vol. 1010, Issue 1, 441–445, Article first published online: 24 JAN 2006

    2. You have free access to this content
      Erratum for Ann. N.Y. Acad. Sci. 1107: 308–318. Autoimmunity, Part C: The Mosaic of Autoimmunity Yehuda Shoenfeld and M. Eric Gershwin, Eds. (page 388)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.046

      This article corrects:

      Role of the HLA Class II

      Vol. 1107, Issue 1, 308–318, Article first published online: 28 AUG 2007

    3. You have free access to this content
      Erratum for Ann. N.Y. Acad. Sci. 1112: 140–153. Thymosins in Health and Disease Allan L. Goldstein and Enrico Garaci, Eds. (page 389)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.047

      This article corrects:

      The Role of DNA and Actin Polymers on the Polymer Structure and Rheology of Cystic Fibrosis Sputum and Depolymerization by Gelsolin or Thymosin Beta 4

      Vol. 1112, Issue 1, 140–153, Article first published online: 10 OCT 2007

    4. You have free access to this content
      Erratum for Ann. N.Y. Acad. Sci. 1113: 304–310. Stress Responses in Biology and Medicine: Stress of Life in Molecules, Cells, Organisms, and Psychosocial Communities Péter Csermely, Tamás Korcsmáros, and Katalin Sulyok, Eds. (page 390)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.048

      This article corrects:

      Cognitive Activation Theory of Stress, Sensitization, and Common Health Complaints

      Vol. 1113, Issue 1, 304–310, Article first published online: 5 NOV 2007

  13. Index of Contributors

    1. Top of page
    2. Preface
    3. Part I. Structure and Function of the Neuromuscular Junction
    4. Part II. Structure and Function of the Acetylcholine Receptor
    5. Part III. Muscle-Specific Kinase and Myasthenia Gravis
    6. Part IV. Congenital Myasthenic Syndromes
    7. Part V. Immunology of Autoimmune Disorders Involving Neuronal and Glial Channel Proteins
    8. Part VI. Autoimmune Pathogenesis of Myasthenia Gravis: Current Concepts
    9. Part VII. Clinical Trials of Myasthenia Gravis
    10. Part VIII. Treatments on the Horizon for Myasthenia Gravis
    11. Part IX. Panel Discussion: Thymectomy for Myasthenia Gravis
    12. List of Abstracts
    13. Erratum
    14. Index of Contributors
    1. Index of Contributors (pages 391–393)

      Article first published online: 28 JUN 2008 | DOI: 10.1196/annals.1405.auindex_1

SEARCH

SEARCH BY CITATION